You are here
A live Infectious Bovine Rhinotracheitis (IBR) vaccine for cattle, to reduce clinical signs and virus excretionassociated with bovine herpesvirus type-1.
Presented as lyophilisate and solvent for suspension. Lyophilisate is an off-white to light pink-coloured pellet and the solvent is a colourless solution.
Each dose of 2 ml reconstituted vaccine contains: Live bovine herpesvirus type 1 (BHV-1), strain GK/D (gE¯ )*: 105.7 - 107.3 TCID50**
* gE¯: glycoprotein E negative
** TCID50 Tissue Culture Infective Dose 50 %
Indications for use
For active immunisation of cattle to reduce the intensity and duration of clinical respiratory signs induced by an infection with BHV-1 as well as to reduce the replication and nasal excretion of the field virus.
Safety and efficacy data are available which demonstrate that re-vaccination -in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR marker live) - this vaccine can be mixed and administered with Bovilis BVD.
Safety and efficacy data -in cattle from 3 weeks of age onwards- are available which demonstrate that this vaccine can be administered on the same day but not mixed with Bovilis Bovipast RSP.
Cattle - milk 0 hours, meat 0 days
Freeze-dried vaccine is supplied in a cardboard box with 1 or 10 vials of glass (hydrolytic type I) with rubber stopper and metal cap. Contents per vial: 5, 10, 25, 50 or 100 doses.
Solvent is supplied in a cardboard box with 1 or 10 vials of glass (hydrolytic type II) or plastic (polyethylene terephthalate) with rubber stopper and metal cap. Contents per vial: Glass: 10, 20, 50, 100 or 200 ml. PET: 100 ml. Not all pack sizes may be marketed.
For full information please refer to the product data sheet. Further information is available on request.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Use Medicines Responsibly.
Date of preparation: September 2020